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Abstract
G protein-coupled receptors (GPCRs) are transmembrane signal transducers which regulate many key physiological pro-
cess. Since their discovery, their analysis has been limited by difficulties in obtaining sufficient amounts of the receptors in 
high-quality, functional form from heterologous expression hosts. Albeit highly attractive because of its simplicity and the 
ease of isotope labeling for NMR studies, heterologous expression of functional GPCRs in E. coli has proven particularly 
challenging due to the absence of the more evolved protein expression and folding machinery of higher eukaryotic hosts. 
Here we first give an overview on the previous strategies for GPCR E. coli expression and then describe the development of 
an optimized robust protocol for the E. coli expression and purification of two mutants of the turkey β1-adrenergic receptor 
(β1AR) uniformly or selectively labeled in 15N or 2H,15N. These mutants had been previously optimized for thermal stabil-
ity using insect cell expression and used successfully in crystallographic and NMR studies. The same sequences were then 
used for E. coli expression. Optimization of E. coli expression was achieved by a quantitative analysis of losses of receptor 
material at each step of the solubilization and purification procedure. Final yields are 0.2–0.3 mg receptor per liter culture. 
Whereas both expressed mutants are well folded and competent for orthosteric ligand binding, the less stable YY-β1AR 
mutant also comprises the two native tyrosines  Y5.58 and  Y7.53, which enable G protein binding. High-quality 1H-15N TROSY 
spectra were obtained for E. coli-expressed YY-β1AR in three different functional states (antagonist, agonist, and agonist + G 
protein-mimicking nanobody-bound), which are identical to spectra obtained of the same forms of the receptor expressed 
in insect cells. NdeI and AgeI restriction sites introduced into the expression plasmid allow for the easy replacement of the 
receptor gene by other GPCR genes of interest, and the provided quantitative workflow analysis may guide the respective 
adaptation of the purification protocol.
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Introduction
The more than 800 G protein-coupled receptors (GPCRs) 
constitute the most abundant class of membrane proteins 
in the human proteome (Alexander et al. 2017) and also the 
most important class of human drug targets, with more than 
30% of all marketed drugs directed against GPCRs (Hauser 
et al. 2017). Since their discovery, the production of prop-
erly folded, active GPCRs has been the major bottleneck for 
biochemical, biophysical and structural studies (Tate 2001; 
Lundstrom et al. 2006; McCusker et al. 2007; Casiraghi et al. 
2018). Despite many advances in protein engineering, clon-
ing, expression, and purification technologies, which have 
led to the experimental elucidation of currently more than 
80 distinct GPCR structures, GPCR production in sufficient 
quantity and quality is still a serious challenge (Wiseman 
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et al. 2020), with low expression levels, low stability, mis-
folding, aggregation, incorrect disulfide bond formation, and 
proteolytic degradation being the main impeding factors.
GPCRs have been expressed in many different hosts com-
prising mammalian cells, insect cells, yeast and E. coli with 
each system presenting particular advantages and disadvan-
tages [for recent review see (Wiseman et al. 2020)]. The 
most successful system are baculovirus-infected insect cells, 
from which about 70% of all solved GPCR structures have 
been derived (Milić and Veprintsev 2015; Saarenpää et al. 
2015; Franke et al. 2018) This success is based on their rela-
tive ease of maintenance as compared to mammalian cells, 
while still harboring the evolved protein translational, fold-
ing, membrane insertion, and posttranslational modification 
mechanisms of higher eukaryotes, which are less developed 
or absent in lower cellular systems such as yeast and E. coli. 
Disadvantages of the insect cell system comprise the tedi-
ous generation of baculoviruses, lengthy culture processes, 
and, with respect to high-resolution heteronuclear NMR, 
the requirement to supply isotope-labeled amino acids to 
the medium, since insect cells do not produce amino acids 
from simple precursors like glucose and ammonium. The 
latter disadvantage can be alleviated to some extent in a cost-
effective manner by feeding isotope-labeled yeast or algal 
extracts to the insect cells (Franke et al. 2018).
In contrast, expression in E. coli offers several particular 
advantages, such as inexpensive (isotope-labeled) growth 
media, easy genetic modification, growth to high cell densi-
ties, and simple and fast scale-up processes. These features 
have made E. coli the most used expression system for solu-
ble proteins. However, heterologous expression of eukaryotic 
membrane proteins is considerably more difficult in E. coli 
for numerous reasons, comprising the lack of the endoplasmic 
reticulum and Golgi apparatus quality control and the more 
evolved post-translational modification (PTM) and membrane 
insertion machineries present in eukaryotes as well as inherent 
toxicity. Nevertheless, many examples exist of the successful 
E. coli expression of important eukaryotic membrane proteins, 
including GPCRs. In order to overcome the described difficul-
ties, almost always empirical optimization of diverse param-
eters such as expression constructs, E. coli strains, induction, 
temperature, etc. is required. Without doubt, protein engineer-
ing towards higher stability has been the most import step to 
the success of GPCR structural studies both in eukaryotic and 
non-eukaryotic expression systems. Such stabilizing sequence 
modifications comprise loop deletions, protein insertions (T4 
lysozyme, rubredoxin, etc.), and extensive point mutations 
(Cherezov et al. 2007; Rosenbaum et al. 2007; Warne et al. 
2008; Sarkar et al. 2008; Shibata et al. 2009; Miller and Tate 
2011). An ingenious method for directed evolution of GPCRs 
in E. coli towards high expression and stability has been devel-
oped by the Plückthun group (Sarkar et al. 2008; Dodevski 
and Plückthun 2011; Schlinkmann et al. 2012) using iterative 
rounds of gene randomization and selection based on fluores-
cence-labeled ligand binding.
Although the work described here uses E.coli in-cell 
expression of GPCRs, we briefly want to mention that also 
cell-free synthesis is possible in E.coli lysates (Henrich et al. 
2015). While the latter method has been successful for the pro-
duction of certain ligand-binding competent GPCRs (Klammt 
et al. 2007; Kögler et al. 2019), a recent NMR characterization 
of the cell-free expressed neurotensin receptor 1 indicated a 
lack of tertiary structure and that further improvements to the 
method were necessary (Shilling et al. 2017).
In the following, we first give an overview on previous 
strategies to produce GPCRs for structural studies from in-
cell E. coli expression and then further develop these into a 
robust, quantitative protocol for the E. coli production of two 
turkey β1-adrenergic receptor (β1AR) mutants, which had 
previously been optimized for thermal stability in insect cells 
and expressed in these eukaryotic cells leading to successful 
crystallization (Warne et al. 2008) and detailed NMR studies 
(Isogai et al. 2016; Abiko et al. 2019; Grahl et al. 2020). The 
first ultrastable β1AR mutant (TS-β1AR, melting temperature 
 Tm = 59 °C), harboring 12 point mutations and truncations 
at the N- and C-termini, is competent for orthosteric ligand 
binding, but deficient in G protein activation (Isogai et al. 
2016). The second TS-β1ARA227Y/L343Y double mutant (named 
YY-β1AR in the following) recovers G protein activation by 
reintroducing the conserved tyrosines  Y5.58 and  Y7.53 [the 
superscript corresponds to Ballesteros-Weinstein numbering 
(Ballesteros and Weinstein 1995)] in TM5 and TM7 at the 
expense of stability  (Tm = 48 °C) (Isogai et al. 2016). Both 
mutants do not carry PTMs such as palmitoylation, which 
were not necessary for successful structural studies. The 2D 
1H-15N NMR spectra of different ligand-bound forms of the 
E. coli-expressed β1AR mutants including a ternary complex 
of YY-β1AR with the agonist isoprenaline and the G protein 
mimicking nanobody Nb80 (Rasmussen et al. 2011) are iden-
tical to spectra obtained from insect-cell expressed receptors. 
The described protocol for E. coli β1AR expression and puri-
fication should be applicable to other GPCRs of sufficient 
stability. Such an adaptation is aided by the quantification of 
receptor amounts at each step of the purification protocol and 
by the introduction of restriction sites into the expression plas-
mid, which allow an easy replacement of β1AR by other GPCR 
genes of interest.
Results and discussion
Overview of previous strategies for GPCR expression 
and purification using E. coli
To learn from past experience, we reviewed 50 of 
the previous studies on GPCR expression in E. coli 
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(Supplementary Table S1). They cover 37 distinct recep-
tors, with the neurotensin receptor (NTS1) being the most 
studied (Fig. 1a). Of the analyzed protocols, 37% used 
expression in inclusion bodies and refolding, whereas 63% 
aimed at the insertion of the properly folded receptor into 
the E. coli inner membrane (Fig. 1c).
Expression in inclusion bodies usually generates high 
amounts of material, but refolding can be very challeng-
ing for GPCRs in particular with regard to finding the 
proper membrane mimetics and the correct formation of 
disulfide bonds. Nevertheless, the CXCR1, Y2, and GRH-
R1a receptors have been obtained from E. coli inclusion 
bodies and refolded into phospholipid bilayers for success-
ful structure determination, modeling or dynamics meas-
urements using solid-state NMR data (Park et al. 2012; 
Schmidt et al. 2014; Schrottke et al. 2017; Bender et al. 
2019).
Expression directed to the membrane has been used for 
many different GPCRs (Bertin et al. 1992; Tucker and Gris-
shammer 1996; Stanasila et al. 1999; Furukawa and Haga 
2000; Hampe et al. 2000; Weiß and Grisshammer 2002; 
Yeliseev et al. 2005; Grisshammer et al. 2005; Dodevski 
and Plückthun 2011) and led to successful structural studies 
of NTS1 (Egloff et al. 2014; Nasr et al. 2017), α1A (Wu et al. 
2020), and α1B (Schuster et al. 2020). In almost all cases, 
membrane insertion has been achieved with an expres-
sion construct originally described for NTS1 (Tucker and 
Grisshammer 1996). In this construct (pRG/III-hs-MBP), 
the receptor is fused at the N-terminus to the periplasmic 
maltose-binding protein (MBP) together with its signaling 
A B
C D E
Fig. 1  Overview of the published studies on GPCR expression in E. 
coli and statistical analysis of the used expression and purification 
strategies: a types of receptors, b detergents, c expression strategy, 
d protein fusion partners, and e purification tags. Details of the used 
data are provided in Supplementary Table S1
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peptide, as well as at the C-terminus to the cytoplasmic 
thioredoxin A (TrxA) followed by a histidine tag. The N-ter-
minal MBP fusion directs the first GPCR helix towards the 
periplasm, thereby inducing the correct orientation of the 
following helices, such that the outside of the folded recep-
tor points to the periplasm and the inside to the cytoplasm. 
MBP is by far the most used fusion protein (42%, Fig. 1d) for 
GPCR E. coli expression. The C-terminal TrxA fusion is not 
important for the proper membrane insertion, but increased 
the expression levels of many receptors (NTS1, CB2, NK1, 
α1A, α2A, CCR3, CCR5, CX3CR1, CXCR4), which appears 
due a stabilizing effect by this soluble, compact protein 
(Tucker and Grisshammer 1996; Yeliseev et al. 2005; Ren 
et al. 2009; Dodevski and Plückthun 2011). Other stable, 
cytosolic proteins such as glutathione S-transferase (GST) 
have also been found to increase GPCR expression yield and 
stability in inclusion bodies (Kiefer et al. 1996; Park et al. 
2012) (Fig. 1d).
Of note, also low temperature (16–25 °C) and low inducer 
concentrations (0.5–0.1 mM IPTG) have been used for the 
majority of natively expressed GPCRs in E. coli to slow 
the transcription rate and ensure correct translocation to the 
membrane without aggregation (Supplementary Table S1).
Once the problems of heterologous expression and mem-
brane insertion are overcome, the next challenging step is the 
extraction from the host membrane. For GPCRs, the most 
common extraction detergents are the maltosides DDM 
and DM mixed with cholesteryl hemisuccinate (CHS), or 
zwitterionic surfactants such as CHAPS (Fig. 1b). It should 
be noted that although alkylphosphocholine (FC) deter-
gents have been widely used for solution NMR studies of 
membrane proteins, there are now many examples showing 
their destabilizing and inactivating effects in particular for 
α-helical proteins (Chipot et al. 2018).
For immunodetection and downstream purification of the 
detergent-solubilized receptors histidine tags fused to the 
C-terminal region are used in most (81%) cases (Fig. 1e). 
In a direct comparison, a  His10 tag proved more efficient for 
nickel affinity purification of NTS1 than a  His6 tag (Gris-
shammer and Tucker 1997).
In the following, we have translated and optimized these 
strategies to the high-yield E. coli expression and purifica-
tion of the two TS-β1AR and YY-β1AR mutants of the turkey 
β1AR, which we had previously used in isotope-labeled form 
from insect cells for NMR dynamical studies (Isogai et al. 
2016; Abiko et al. 2019; Grahl et al. 2020).
Optimization of the expression vector
The TS-β1AR mutant (Isogai et al. 2016) was first cloned 
from the insect cell vector into the E. coli expression vec-
tor pRG/III-hs-MBP (Tucker and Grisshammer 1996). In 
the original pRG/III-hs-MBP, TS-β1AR is linked to the 
N- and C-terminal MBP and Trx fusion proteins via throm-
bin protease cleavage sites. However, cleavage by throm-
bin resulted in aggregation of the receptor. Therefore, we 
replaced these sites by cleavage sites for the more selective 
HRV 3C protease (Waugh 2011), and additionally separated 
them on each side from the protein sequences by (GS)5 
linkers (Fig. 2a). Using HRV 3C overcame the aggregation 
problem, while the (GS)5 linkers increased the efficiency of 
HRV 3C cleavage by about 70%, apparently by making the 
cleavage sites more accessible. To facilitate the use of the 
construct for other GPCRs or transmembrane proteins and 
replacement by respective genes of interest, we also added 
the two endonuclease restriction site sequences NdeI and 
AgeI upstream and downstream of the β1AR gene (Fig. 2a). 
The YY-β1AR mutant vector, which encodes the G protein 
binding-competent β1AR, was obtained from this TS-β1AR 
vector by reintroducing the two native tyrosines via the point 
mutations A227Y and L343Y.
Protein expression
Following previous experience (Supplementary Table S1), 
the β1AR expression in E. coli was carried out at a reduced 
temperature of 22 °C as described previously to slow down 
protein synthesis and increase the efficiency of lipid bilayer 
insertion (Hampe et al. 2000; Weiß and Grisshammer 2002; 
White et al. 2004; Shibata et al. 2009). Minimal media were 
used throughout to optimize for isotope labelling in NMR 
experiments. Several parameters were screened to improve 
the expression levels of the TS-β1AR vector as quantified 
by western blot against the C-terminal  His10 tag. Of the four 
tested E. coli strains standard BL21(DE3) and its derivatives 
pLysS, Rosetta 2, and (CodonPlus) RIL (Fig. 2b), Rosetta 
2 achieved the highest expression level. This was followed 
by 20–30% lower expression levels for pLysS and RIL. The 
standard BL21(DE3) cells expressed only a third of Rosetta 
2. The higher expression levels of Rosetta 2 and RIL must 
result from their additional tRNAs for rare E. coli codons. Of 
note, the TS-β1AR gene had been taken from the insect cell 
expression vector and not been codon-optimized for E. coli. 
As an alternative, the receptor gene may be codon-optimized 
for E. coli, but such a strategy may become costly when 
studying a large number of different receptors (Petrovskaya 
et al. 2010). The increased expression level of pLysS may 
be attributed to the better suppression of basal expression 
in these cells.
We also tested the effect of cholesterol, since it has been 
reported to stabilize GPCRs (Gimpl and Fahrenholz 2002; 
Pucadyil and Chattopadhyay 2006; Prasanna et al. 2014) 
and indeed also stabilizes TS-β1AR (see below). However, 
the addition of 20 mg/L cholesterol to the growth medium 
had no effect on the expression level (Fig. 2c), but retarded 
considerably (~ twofold) E. coli growth. Also a longer 
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expression time (48 h) showed no improvement in compari-
son to overnight cultures (Fig. 2d).
Based on these test results, all subsequent expressions 
were carried out using Rosetta 2 without addition of choles-
terol in overnight cultures.
Membrane solubilization
Three different conditions were tested for membrane solu-
bilization: 1.5% DM, 1.5% DM + 0.7% CHAPS + 0.15% 
CHS (cholesteryl hemisuccinate), and 1.5% DDM + 0.7% 
CHAPS + 0.15% CHS (Fig. 2e). We had previously used 
1.5% DM to extract β1AR from the insect cell membranes 
with good results. However, the DM extraction efficiency 
was very low for the E. coli membrane and increased con-
siderably when 0.7% CHAPS + 0.15% CHS were added. 
The efficiency further increased when replacing DM by the 
longer-chain DDM. Thus the most widely used detergent 
mixture to extract GPCRs from E. coli membranes (Fig. 1b) 
also proved most efficient for TS-β1AR. Of note, addition 
of CHS also increases the TS-β1AR temperature stability 
(see below).
As we had previously found that the quality of NMR 
spectra and long-term stability was best for TS-β1AR in DM 
micelles (Isogai et al. 2016), the β1AR mutants solubilized 
by the DDM/CHAPS/CHS mixture from the E. coli mem-
brane were exchanged to DM during the subsequent purifica-
tion steps, which were carried out with 0.15% (nickel affin-
ity) or 0.1% of DM (ion exchange and alprenolol affinity).
Purification strategy
The purification procedure after the membrane solubiliza-
tion was adapted from the previous protocol for insect cell-
expressed β1AR (Isogai et al. 2016). The individual steps of 
both E. coli and insect cell purification protocols are shown 
in Fig. 3. The purification consists sequentially of nickel 
affinity, fast-flow cationic ion exchange, alprenolol affinity 
(ALAC), and high-performance cationic ion exchange chro-





Fig. 2  Fusion protein construct for β1AR expression in E. coli and 
tests for expression and solubilization optimization. a Fusion protein 
construct for E. coli expression based on the pRG/III-hs-MBP plas-
mid (Tucker and Grisshammer 1996). The different sequence parts 
are labeled for maltose-binding protein (MBP), glycine-serine linker 
(GS)5, HRV 3C protease cleavage sites (3C, residues LEVLFQ↓GP), 
NdeI and AgeI restriction sites, thioredoxin A (TrxA), and a deca-
histidine tag  (H10). b–e Expression and solubilization tests quantified 
by western blot. The number under each band represents its relative 
intensity compared to the strongest band in the gel. b Expression test 
using different E. coli strains. c Expression test in the absence (−) or 
in the presence (+) of 20 mg/L cholesterol. d Test of the influence of 
the expression duration after induction. e Test of membrane solubi-
lization using different detergent mixtures. The solubilized fractions 
were subjected to nickel-affinity chromatography and eluted by the 
same buffer for all the samples (20 mM Tris pH 7.5, 350 mM NaCl, 
250 mM imidazole, 0.15% DM) before quantification by western blot
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The first, fast flow cation exchange (SPFF) chromatogra-
phy removes many impurities, which are still present in the 
nickel-eluted fraction, and concentrates the receptor from 
the large elution volume (90 mL to ~ 25 mL for 4 L culture). 
This is important for the subsequent ALAC step, since the 
alprenolol-sepharose resin has low binding capacity (Caron 
et  al. 1979) and the ALAC column requires slow load-
ing (0.1 mL/min). The ALAC step retains only the ligand 
binding-competent protein and is crucial for a homogene-
ous sample. The second, high-performance cation exchange 
(SPHP) chromatography following the ALAC confers an 
ultra-pure sample and also concentrates the receptor in a 
mild way without aggregation from the 60-mL ALAC eluate 
to about 4 mL.
The major difference of the E. coli β1AR construct 
relative to the insect cell construct is the presence of the 
MBP and TrxA fusion partners. Thus it is a crucial ques-
tion at which point of the protocol these fusion partners are 
removed by cleavage. Since MBP, TS-β1AR and TrxA have 
very distinct isoelectric points (4.8, 9.6, and 4.3, respec-
tively), the fusion protein is hard to purify by either cati-
onic or anionic ion exchange chromatography. In contrast, 
the cleaved β1AR is readily separated from MBP and TrxA 
by ion exchange chromatography. Indeed, cleavage car-
ried out directly after the nickel affinity step instead of the 
ALAC increased the yield of purified TS-β1AR from 0.17 
to 0.25 mg/L in a direct comparison.
Quantitative analysis of the purification steps
The efficiencies of the individual steps in the E. coli and 
insect cell purification protocols were determined by quan-
tifying western blots or Coomassie-stained gels (Supple-
mentary Figure S1). These efficiencies are indicated in the 
overall flow diagrams for the two protocols (Fig. 3). Of note, 
the E. coli purification extends over three days instead of the 
two days for the insect cell purification due to the additional 
overnight cleavage step.
Apparently, solubilization was more efficient from E. coli 
(81%) than from insect cells (56%). As this might have been 
caused by the different detergent used (1.5% DDM, 0.7% 
CHAPS, 0.15% CHS vs. DM), we also tested solubiliza-
tion of the insect cell material by the DDM/CHAPS/CHS 
mixture. However, no increase in efficiency was observed. 
Thus the effect must be due to the different membrane com-
position of E. coli and insect cells. During the following 
nickel affinity step, the detergent is exchanged for the E. coli 
material to DM. During this step considerably more β1AR 
was recovered from the E. coli material (71%) than from 
the insect cell material (48%). A test with DDM/CHAPS/
CHS-solubilized insect cell material showed that the higher 
yield for the E. coli material in this step was not due to the 
different detergent mixture. The following cleavage of the 
E. coli material by the HRV 3C protease was highly efficient 
(92%). After this step both E. coli and insect cell-derived 
β1AR samples should be identical in their composition.
Considerable amounts of material are lost in the subse-
quent purification steps. From the β1AR E. coli material only 
23% are recovered after the SPFF ion exchange step in con-
trast to 47% for the insect cell material. Similarly, also the 
ALAC column is less efficient for the E. coli (38%) vs. the 
insect cell (61%) material. We attribute these higher losses 
for the E. coli material to a appreciably larger fraction of 
misfolded protein present in this preparation. After filtering 
out these misfolded receptors, the second cationic exchange 
elution has similar efficiency for both preparations (41% E. 
coli vs. 33% insect cell).
The final yields for TS-β1AR and the less stable YY-β1AR 
mutant purified from E. coli were 1.2 and 0.9 mg from 4-L 
minimal media cultures, respectively. These yields are about 
Fig. 3  Purification schemes 
with timeline and yields for 
β1AR expressed in E. coli and 
Sf9 cells. Each work day of 
the purification is indicated 
by a blue box. Receptor yields 
estimated by quantifying the 
SDS or western-blot gels are 
indicated relative to the previ-
ous step by red numbers
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4 times smaller than from insect cell cultures, but similar 
to other GPCRs produced from E. coli under native condi-
tions, such as the CB1 and α1A receptors (Link et al. 2008; 
Wu et al. 2020).
Thermal stability quality tests
As a first test of the quality of the E. coli-derived receptors 
we used the common CPM (N-[4-(7-diethylamino-4-methyl-
3-coumarinyl)phenyl] maleimide) microscale fluorescent 
stability assay. Both E. coli- and insect cell-derived apo 
TS-β1AR showed the same well-defined melting tempera-
ture  Tm of 62 °C (Fig. 4a). Of note, the melting temperature 
of the entire, uncleaved MBP-TS-β1AR-TrxA fusion protein 
 (Tm = 61 °C) is also close to the values of the isolated recep-
tor. As observed previously for insect cell-derived β1AR 
(Warne et al. 2009), binding of the antagonist carvedilol 
increased  Tm for the E. coli-derived TS-β1AR by about 15 
°C (Fig. 4b). Also the addition of 0.1% CHS increased  Tm 
to 72 °C, while glycerol showed no effect.
Isotope labeling and NMR spectra
15N-labeled samples of TS-β1AR and YY-β1AR were pro-
duced with no difficulties using the common E. coli M9 min-
imal medium for isotope labelling (Green et al. 2012). As a 
test for proper function, 1H-15N TROSY spectra of 15N-YY-
β1AR (Fig. 5) were recorded in binary complexes with the 
antagonist cyanopindolol, the agonist isoprenaline, and in 
the ternary complex with isoprenaline and the nanobody 
Nb80, which binds in the same way to the intracellular side 
of the receptor as the full G protein (Rasmussen et al. 2011). 
For each of these distinct functional states, well-dispersed 
1H-15N resonances were observed, which are typical of a 
properly folded protein. Figure 5 shows a superposition of 
these spectra from uniformly 15N-labeled YY-β1AR obtained 
from E. coli with spectra from selectively 15N-valine (panel 
A) or 15N-tyrosine (panel B) labeled YY-β1AR obtained 
from insect cells in complexes with the same ligands. 
Clearly the resonances from the sparsely labeled insect cell 
samples are in very similar positions. In particular, the 1H-
15N resonances of V172, V202 and V314, which are located 
close to the orthosteric ligand head group and the extracel-
lular entrance of the ligand pocket (Fig. 5c), show identical 
strong variations in the various complexes. These have been 
identified previously (Abiko et al. 2019; Grahl et al. 2020) 
with the inactive conformation (cyanopindolol), a mixture 
in slow chemical exchange between preactive and active 
conformation (isoprenaline), and the active conformation 
(isoprenaline + Nb80).
For a more direct comparison with the selectively 
15N-valine labeled receptor (TS-β1AR) obtained from insect 
cells, we also attempted 15N-valine selective labeling in 
E. coli by the addition of 15N-valine to the unlabeled M9 
medium. This yielded the same amount of protein as from 
uniformly 15N-labeled M9. The TROSY spectrum of cyan-
opindolol-bound TS-β1AR shows similar resonances as the 
spectrum of 15N-valine labeled TS-β1AR from insect cells, 
e.g. for V172, V202, and V314 (Supplementary Figure S2). 
However, due to the metabolic scrambling of 15N-valine to 
alanine, isoleucine, glutamate and other branched amino 
acids (Lacabanne et al. 2018; Sugiki et al. 2018), many addi-
tional non-valine resonances are observed for the E. coli-
derived receptor whereas the valine resonances are relatively 
A B
Fig. 4  Quality test of E. coli-derived β1AR by the CPM thermal shift 
assay. a Thermal stability of E. coli-derived full-length MBP-TS-
β1AR-TrxA and TS-β1AR in comparison to insect-derived TS-β1AR 
(all apo forms). Samples contained ~ 25 μM receptor in 20 mM Tris, 
1 mM EDTA, 750 mM NaCl, 0.1% DM, pH 7.5. b Thermal stabil-
ity of E. coli-derived TS-β1AR in the presence of various additives. 
The CPM fluorescence signal (F) is shown as its first derivative (dF/
dT). Triplicates of the experiments are shown color-coded by identi-
cal colors
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weakened (e.g. V95, which is already weak in the insect cell 
spectrum, is not even detected in the E. coli spectrum). We 
attribute these effects to the depletion of the 15N-labeled 
valine pool from the efficient two-way scrambling and also 
to the higher mobility of non-valine residues located in 
surface loops or tails. In principle, the scrambling may be 
reduced by the use of auxotrophic E. coli strains (Lin et al. 
2011), but this approach was not further pursued.
We also tested the production of uniformly 2H,15N-
labeled TS-β1AR in E.coli by growing the bacteria in 
15N-labeled M9 medium and 100%  D2O using standard 
protocols (Opitz et al. 2019). Protein expression was about 
half of the amount obtained in 15N M9 medium in  H2O. Such 
reductions in yield are not uncommon for deuterated media, 
since bacterial growth and metabolism are affected by deu-
teration (Opitz et al. 2019). Improvements in yield may be 
achievable by multiple rounds of adaptation and selection or 
the use of optimized strains (Paliy et al. 2003; Kelpšas and 
Wachenfeldt 2019).
An NMR sample of 2H,15N-labeled TS-β1AR in complex 
with the antagonist alprenolol was prepared from this E. coli 
culture by carrying out the entire solubilization and purifi-
cation procedure in  H2O. Figure 6a shows a comparison of 
TROSY spectra of this 2H,15N-labeled TS-β1AR alprenolol 
complex and an identical complex prepared from insect cell-
derived TS-β1AR with about 60% 2H and 90% 15N incorpo-
ration. The latter was obtained by growing insect cells in 
 H2O and supplying 2H/15N-labeled amino acids via respec-
tively labeled yeast extract (Opitz et al. 2015). Clearly the 
1H/15N resonance positions are very close in both spectra 
indicating that the 2H,15N-labeled TS-β1AR from E. coli is 
in the same well-folded state as the TS-β1AR from insect 
cells. However, fewer 1H/15N resonances are observed for 
the E. coli material. A histogram of the intensity ratios 
of the resonances from the insect cell and E. coli samples 
(Fig. 6b) reveals that about a third of the resonances are sig-
nificantly more intense in the insect cell sample. We attrib-
ute this effect to the incomplete back exchange of amide 
A C
B
Fig. 5  Comparison of 1H-15N TROSY spectra of 15N-labeled 
YY-β1AR derived from E. coli and Sf9 insect cells. Spectra are 
shown for YY-β1AR binary complexes with the antagonist cyano-
pindolol and the agonist isoprenaline, as well as the ternary complex 
with isoprenaline and the G protein-mimicking Nb80. All the experi-
ments were carried out at 304 K, with samples containing ~ 100 μM 
receptor complexes in 20  mM Tris, 1  mM EDTA, 100  mM NaCl, 
37 mM DM, 0.02%  NaN3, 5%  D2O, pH 7.5. a Superposition of spec-
tra of uniformly 15 N-labeled YY-β1AR obtained from E. coli (blue) 
and 15  N-valine labeled YY-β1AR obtained from Sf9 cells (red). b 
Superposition of spectra of uniformly 15N-labeled YY-β1AR obtained 
from E. coli (blue) and 15N-tyrosine labeled YY-β1AR obtained from 
Sf9 cells (magenta). Where available, resonances are marked with 
assignment information. c Crystal structure of β1AR in complex with 
isoprenaline (green, PDB code 2Y03). Valine residues observed and 
assigned in panels a and b are shown as red spheres
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protons during the purification in  H2O. This is corroborated 
by the observation that most of the missing resonances are 
located in the 1HN downfield region. These 1HN nuclei are 
part of short hydrogen bonds in well-formed, stable sec-
ondary structure elements (Grzesiek et al. 2004). It is obvi-
ous that better back exchange of amide protons is necessary 
for the E. coli-derived 2H,15N-labeled TS-β1AR. This may 
achievable by slight destabilization of the receptor at higher 
temperature, higher pressure or by chemical denaturants. 
Other researcher in the field have reported similar problems 
of amide proton back exchange for GPCRs grown in 100% 
deuterated media (K. Wüthrich, personal communication).
Conclusions
We have presented here an optimized protocol for E. coli 
expression and purification of two β1AR constructs, which had 
previously been engineered in insect cells for thermal stability 
and subsequent successful structural and dynamical studies. 
Of note, this protein engineering comprises the removal of the 
N-terminal glycosylation and C-terminal palmitoylation, as is 
often the case in solved GPCR structures (Munk et al. 2019). 
Thus the absence of the respective PTM machineries did not 
present a problem for the E. coli expression. Our protocol uses 
the same genes as in the insect cells and was optimized for 4-L 
cultures, yielding 0.9 mg of the fully active YY-β1AR, and 
1.2 mg for the more thermostable TS-β1AR construct, which 
is about a quarter of the insect cell yield.
The E. coli sample quality is identical to the insect cell 
material as assayed by the thermal melting behavior and a 
direct comparison of backbone 1H-15N spectra of the same 
receptor constructs obtained from insect cells in 3 different 
functional states. As such the E. coli-derived β1AR is usable 
for any structural or biophysical study in the same way as 
β1AR derived from insect cells.
While the purification steps and time are similar for insect 
cell- and E. coli-derived receptors, genetic manipulations are 
much simpler and protein expression is much faster in E. coli. 
The production of baculovirus and the scaling-up of insect cell 
cultures typically takes weeks, whereas bacterial expression 
can be achieved within two days. Furthermore, E. coli offers 
the advantage of efficient, low-cost, and highly developed pro-
cedures (Boisbouvier and Kay 2018) for uniform and very 
specific isotope labeling.
The approach presented here should be easily transferable 
to other GPCRs of interest by using the standard restriction 
sites introduced into the expression plasmid and by compar-
ing the yields at the described quantitative checkpoints in the 
purification procedure.
A B
Fig. 6  Comparison of 1H-15N TROSY spectra of 2H,15N-labeled 
YY-β1AR derived from E. coli and Sf9 insect cells. a 1H-15N TROSY 
spectra of 17  μM uniformly 2H,15N-labeled TS-β1AR derived from 
E. coli (blue) and of 90  μM 60% 2H, 90% 15N-labeled TS-β1AR 
expressed in baculovirus-infected Sf9 insect cells (red). Both samples 
contained 1 mM of the antagonist alprenolol in 20 mM Tris, 1 mM 
EDTA, 100 mM NaCl, 37 mM DM, 0.02%  NaN3, 5%  D2O, pH 7.5. 
Experiments were carried out at 304 K with total experimental times 
of 67  h and 10.5  h for the E. coli and Sf9 samples, respectively. b 
Histogram of intensity ratios  (ISf9/IE. coli) of Sf9 and corresponding 
E. coli 1H-15N TROSY resonances. Intensities ratios of resonances 
present in both spectra are shown as brown histogram bars. For reso-
nances, which were only detected in the Sf9 sample,  ISf9/IE. coli was 
approximated by the intensity of the Sf9 resonance divided by 3 times 
the standard deviation of the noise of the E. coli spectrum. These 
cases then present a lower limit for  ISf9/IE. coli and are shown in dark 
yellow




An optimized expression construct for the turkey β1AR 
receptor was derived from the vector pRG/III-hs-MBP 
kindly provided by R. Grisshammer (NIH) by (i) replace-
ment of the NTS1 gene by the thermostabilized TS-β1AR 
receptor DNA sequence by restriction-free cloning (van 
den Ent and Löwe 2006), (ii) introduction of two 3C cleav-
age sites between the MBP and TS-β1AR and between the 
TS-β1AR and TrxA sequences by site-directed mutagen-
esis, (iii) addition of two (GS)5 spacers before and after 
each 3C cleavage site by megaprimer cloning (Zhang 
et al. 2017), and (iv) introduction of NdeI and AgeI cleav-
age sites upstream and downstream of the TS-β1AR gene 
sequence by site-directed mutagenesis (Hemsley et al. 
1989). The final fusion protein sequence is summarized 
in Fig. 2a and the TS-β1AR sequence after the cleavage of 












For the YY-β1AR construct, the two native tyrosine 
residues Y227 and Y343 were introduced into TS-β1AR 
sequence by site-directed mutagenesis. The molecu-
lar weight of both TS-β1AR and YY-β1AR proteins 
is ~ 38 kDa.
Expression of uniformly 15N‑labeled β1AR in E. coli
Chemically competent Rosetta 2(DE3) (Novagen) cells 
were transformed with the optimized expression vectors by 
heat shock and frozen as a glycerol stock. 100 μL thawed 
glycerol stock were then used to grow a 5-mL inocu-
lum in Luria–Bertani (LB) medium at 37 °C for 9–10 h. 
The LB culture was diluted with ~ 100 mL M9 minimal 
medium (supplemented with 4 g/L of glucose and 1 g/L 
of 15NH4Cl) to  OD600 = 0.1 and grown overnight at 37 °C. 
On the next day, the culture was diluted into 4 L M9 to 
 OD600 = 0.1 and grown at 37 °C until the  OD600 reached 
0.6. Subsequently, the temperature was reduced to 22 °C 
and the culture further grown to  OD600 = 0.9. At this point, 
the expression was induced with 0.25 mM isopropyl-β-
D-thiogalactoside (Sigma-Aldrich) and growth continued 
for 16 h at the same temperature. Then cells were pelleted 
for 15 min at 5000 r.p.m., resuspended in 70 mL 20 mM 
Tris pH 7.5, 1 mM EDTA containing 2 tablets of cOm-
plete™ protease inhibitor cocktail (Hoffmann-La Roche), 
flash-frozen in liquid nitrogen, and stored at -80 °C until 
purification.
For testing the effect of cholesterol on expression, a cho-
lesterol stock solution of 20 g/L was prepared in ethanol and 
added to the M9 media to a final concentration of 20 mg/L 
before inoculation.
Expression of 15N‑valine‑labeled β1AR in E. coli
15N-valine-labeled β1AR in E. coli was expressed as 
described for the 15N-labeled protein with the exception of 
adding 100 mg/L 15N-valine (Sigma-Aldrich) and 30 mg/L 
leucine to the 14N4HCl-containing M9 medium.
Expression of uniformly 2H,15N‑labeled TS‑β1AR 
in E. coli
Uniformly 2H,15N-labeled TS-β1AR was expressed in E. coli 
using M9 medium prepared in  D2O (> 90%) supplemented 
with 4 g/L of glucose and 1 g/L of 15NH4Cl as described 
for protonated M9. Prior to expression, cells were gradually 
adapted to the deuterated medium by 9–16 h steps of growth 
at 37 °C in 0/100, 30/70, 70/30, and 100/0% deuterated/
protonated medium, respectively.
Membrane fraction preparation
Unless otherwise stated, all β1AR purification steps were 
carried out at 4 °C. Thawed cells from a 4-L culture were 
passed 3 times through a pre-cooled French pressure cell 
at 2000 psi and ultra-centrifuged at 140,000×g for 1 h. For 
solubilization, the pellet was suspended in 120 mL 20 mM 
Tris pH 7.5, 400 mM NaCl, 2.5 mM imidazole, 1.5% DM, 
0.7% CHAPS, 0.15% CHS (all detergents obtained from 
Anatrace). Solubilization was achieved in three steps: (1) 
2 × 5 s treatment with an electric homogenizer (Ultra TUR-
RAX™, IKA) equipped with a 7-mm saw tooth dispersing 
probe at 11.000 r.p.m.; (2) homogenization with a tight-pis-
ton Dounce homogenizer; and (3) 2 h of incubation under 
gentle motion in a roller mixer (Stuart Scientific). The solu-
bilized cells were then ultra-centrifuged at 140,000×g for 
30 min. The supernatant containing the solubilized recep-
tor was used for further purification, whereas ¼ of the pellet 
was resolubilized in 30 mL 20 mM Tris pH 7.5, 200 mM 
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NaCl, 7 M urea for quantification of the remaining insoluble 
receptor.
Membrane solubilization test
For quantifying the efficiency of membrane solubilization 
by different detergents, the cells from a 2-L E. coli culture 
were disrupted, divided into 3 equal parts, and centrifuged 
as described above. The 3 pellets were then suspended, each 
in 10 mL 20 mM Tris pH 7.5, 400 mM NaCl, 2.5 mM imida-
zole + either 1.5% DM or (1.5% DM + 0.7% CHAPS + 0.15% 
CHS) or (1.5% DDM + 0.7% CHAPS + 0.15% CHS). Sol-
ubilization under mechanical agitation and further cen-
trifugation were then carried out as described above. The 
solubilized supernatant of each sample was purified by Ni 
affinity and quantified for receptor content by western blot 
as described below.
Protein purification
The solubilized membrane fraction was incubated for 2 h in 
a rotator mixer with 15 mL (50% slurry) of Ni–NTA agarose 
resin (Qiagen) which had been pre-equilibrated with 20 mM 
Tris pH 7.5, 350 mM NaCl. The resin was washed using two 
centrifugation (5 min, 1000 r.p.m, in an Eppendorf 5430 R 
centrifuge) and resuspension steps (90 mL 20 mM Tris pH 
7.5, 850 mM NaCl, 15 mM imidazole, 0.15% DM; 70 mL 
of 20 mM Tris pH 7.5, 350 mM NaCl, 15 mM imidazole, 
0.15% DM). The washed resin was placed in a column on 
top of 2 mL additional resin. β1AR was eluted by grav-
ity flow with 90 mL 20 mM Tris pH 7.5, 350 mM NaCl, 
250 mM imidazole, 0.15% DM. This eluted fraction was 
then incubated overnight with 20 mg of home-made 3C pro-
tease [produced according to (Ullah et al. 2016)] in a rotator 
mixer (Stuart Scientific).
On the following day, this fraction incubated with 3C 
protease was diluted to a volume of 180 mL with buffer 
IEX A (20  mM Tris pH 7.5, 1  mM EDTA, 0.1% DM) 
and applied to a 5 mL SP Sepharose™ Fast Flow cation 
exchange column (GE healthcare), washed with 20 mL of 
buffer IEX A, and eluted with a gradient from 5 to 100% of 
buffer IEX B (20 mM Tris pH 7.5, 1 mM EDTA, 2 M NaCl, 
0.1% DM). β1AR eluted at ~ 30% of IEX B. The eluted peak 
was collected and applied to a 5-mL alprenolol-sepharose 
affinity column (ALAC) prepared as described in (Hemsley 
et al. 1989). Non-binding protein was slowly washed out 
(0.1 mL/min) with 60 mL 20 mM Tris pH 7.5, 1 mM EDTA, 
750 mM NaCl, 0.1% DM and the binding-competent β1AR 
was eluted with 60 mL of the same buffer containing 1 mM 
of the inverse-agonist atenolol.
The eluted fraction from the ALAC was diluted to 200 mL 
with buffer IEX A and applied to a 5-mL SP Sepharose™ 
High Performance column (GE healthcare), washed with 
20 mL buffer IEX A, and eluted with a gradient from 7 to 
90% of IEX B. The pure, homogeneous β1AR eluted at ~ 49% 
of IEX B. This fraction was collected, buffer-exchanged to 
20 mM Tris pH 7.5, 1 mM EDTA, 100 mM NaCl, 0.1% 
DM and concentrated to ~ 250 μL using a 50-kDa molecular 
weight cut-off Amicon centrifugal filter (Millipore). Recep-
tor concentrations were estimated by  OD280 using a Nano-
Drop (Thermo Scientific™) UV–Vis spectrophotometer and 
a theoretical extinction coefficient of 66,055 M−1 cm−1.
For complex formation with the higher-affinity, ortho-
steric ligands cyanopindolol or isoprenaline, the low-affinity 
ligand alprenolol was exchanged as described previously 
(Isogai et  al. 2016). In brief, the samples were washed 
repeatedly first with buffer devoid of ligand and then with 
buffer containing the higher-affinity ligand of interest. 
Final ligand concentrations were 1 mM cyanopindolol or 
2 mM isoprenaline (+ 20 mM sodium ascorbate for stabil-
ity). For formation of the ternary YY-β1AR complex, a 1.2 
molar equivalent of Nb80 [prepared as described previ-
ously (Rasmussen et al. 2011)] was added to the preformed 
isoprenaline∙YY-β1AR complex.
Expression and purification of selectively 15N‑valine‑, 
15N‑tyrosine‑, and uniformly 2H,15N‑labeled β1AR 
from Sf9 insect cells
Expression of the 15N-valine-labeled YY-β1AR in baculo-
virus-infected Sf9 cells, purification, and assignments were 
carried out as described previously (Isogai et al. 2016). 
15N-tyrosine labeled YY-β1AR was expressed similar to 
 the15N-valine-labeled receptor by replacing the 100 mg/L 
15N-valine by 150 mg/L 15N-tyrosine in the expression 
media. 60% 2H, 90% 15N-labeled TS-β1AR was expressed 
in baculovirus-infected Sf9 insect cells grown on 2H-15N-la-
beled yeast extract and purified as described previously 
(Opitz et al. 2015).
Quantitative analysis of receptor from gel 
electrophoresis and western blotting
At every step of the purification, the amount of receptor 
was quantified by SDS/PAGE followed by western blot-
ting against the histidine-tagged receptor using chemilumi-
nescence. For this, 10 μL of the respective fractions were 
diluted with 10 μL SDS–PAGE buffer (125 mM Tris–HCl 
pH 6.8, 4% (w/v) SDS, 20% (v/v) glycerol and 0.01% (w/v) 
bromophenol blue) and loaded onto Mini-PROTEAN 
TGX™ 4–20% precast gels (Bio-Rad). As a reference, 7 μL 
of Precision Plus Protein™ dual color standard weight lad-
der (#1610374, Bio-Rad) were also loaded onto the gel, and 
the proteins separated for 30 min at 200 V. The gel was then 
stained with Coomassie brilliant blue and images recorded 
using an Epson Perfection V800 Photo scanner at 600 dpi 
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resolution. Fractions from the different steps of the prepara-
tion loaded onto the same gel were quantified in their rela-
tive β1AR amount by densitometry (see below).
For better identification and quantification β1AR was also 
analyzed by western blots in the early purification steps. 
For this, proteins were transferred to 0.2 μm nitrocellulose 
membranes using the Trans-Blot Turbo™ transfer system 
(Bio-Rad). Western-blot membranes were treated with HRP 
anti-His tag antibody (BioLegend) and Lumi-Light Western 
Blotting Substrate (Hoffmann-La Roche). The chemilumi-
nescence signal was detected using a Fusion FX6 reader 
(Vilber) at 600 dpi resolution.
Individually selected bands of the obtained images from 
the SDS-PAGE gels and from the western blot membranes 
were quantified by ImageJ (Schindelin et al. 2012) after 
background subtraction using the rolling ball radius method 
(50 pixels).
Thermal stability assays
The melting temperatures of the full-length MBP-TS-β1AR-
TrxA fusion and of TS-β1AR isolated from E. coli as well 
as insect cells under various conditions were determined by 
following the fluorescence of added N-[4-(7-diethylamino-
4-methyl-3-coumarinyl)phenyl]maleimide (CPM) using a 
Qiagen Rotorgene QPCR thermocycler. For this, ~ 1.5 μL 
of ~ 1 mg/mL receptor were diluted in 20 mM Tris pH 7.5, 
1 mM EDTA, 750 mM NaCl, 0.1% DM, 1 mM atenolol (and 
optionally 10% glycerol, 0.1% CHS, or 1 mM carvedilol) to 
a final volume of 60 μL and incubated for 1 h on ice. After 
incubation, 5 μL of a 186 μM solution of CPM in DMSO 
was added to each sample (final concentration ~ 14 μM). 
The GPCR thiol-CPM conjugate fluorescence (excitation 
387 nm, emission 463 nm) was monitored while increasing 
the temperature from 25 to 90 °C at a rate of 2 °C/minute. 
For every condition, 3 replicates were measured.
NMR experiments
NMR samples were prepared in 5-mm Shigemi tubes 
as ~ 250-μL volumes of ~ 100 μM protonated (~ 20 μM E. 
coli-derived deuterated) receptor complexes in 20 mM Tris 
pH 7.5, 1 mM EDTA, 100 mM NaCl, 37 mM DM, 0.02% 
 NaN3, 5%  D2O. All NMR experiments were carried out on a 
Bruker AVANCE 21.2 T (900 MHz) spectrometer equipped 
with a TCI cryoprobe at a temperature of 304 K. Unless 
stated otherwise, 1H-15N TROSY experiments were recorded 
as 80/120 (15N) × 1024 (1H) complex points with acquisi-
tion times of 16/24 ms (15N) and 42 ms (1H) for protonated/
deuterated samples, respectively. For optimal sensitivity, 
the 1H-15 N transfer time was reduced to 3.0 ms using a 1 s 
interscan delay. Typical total experimental times were 48 h.
All NMR spectra were processed with NMRPipe (Dela-
glio et  al. 1995) and evaluated with CcpNmr Analysis 
(Vranken et al. 2005).
Supporting information
Supplementary Figures S1, S2 showing details of β1AR 
expression optimization and purification as well as TROSY 
spectra of 15N-valine selectively labeled TS-β1AR; Supple-
mentary Table S1 giving an overview of the most important 
approaches used in previous studies of GPCR expression 
in E. coli.
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